Liu SM, Yan HH, Wei XW, Lu C, et al. Biomarker-Driven Studies With Multi-targets and Multi-drugs by Next-Generation Sequencing for Patients With Non-Small-Cell Lung Cancer: An Open-Label, Multi-center, Phase II Adaptive Umbrella Trial and a Real-World Observational Study (CTONG1702&CTONG Clin Lung Cancer 2022 May 11. pii: S1525-7304(22)00101.
PMID: 35659479